Alley Investment Management Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Sell
12,873
-8
-0.1% -$8.17K 1.8% 22
2026
Q1
$11.8M Sell
12,881
-79
-0.6% -$80.1K 1.44% 30
2025
Q4
$13.9M Sell
12,960
-141
-1% -$135K 1.63% 26
2025
Q3
$10M Buy
13,101
+44
+0.3% +$32.7K 1.16% 37
2025
Q2
$10.2M Buy
13,057
+68
+0.5% +$52.8K 1.23% 35
2025
Q1
$10.7M Buy
12,989
+40
+0.3% +$33.3K 1.35% 33
2024
Q4
$10M Buy
12,949
+137
+1% +$113K 1.26% 36
2024
Q3
$11.4M Buy
12,812
+2,126
+20% +$1.91M 1.44% 32
2024
Q2
$9.67M Buy
10,686
+63
+0.6% +$50.4K 1.32% 38
2024
Q1
$8.26M Buy
10,623
+38
+0.4% +$27K 1.14% 40
2023
Q4
$6.17M Buy
10,585
+3,626
+52% +$2.12M 0.9% 43
2023
Q3
$3.74M Buy
+6,959
New +$3.59M 0.63% 52

Other funds holding LLY

Alley Investment Management Company's LLY Position: Q2 2026 in Review

Alley Investment Management Company reduced its Eli Lilly (LLY) stake by 0.06% in Q2 2026, selling an estimated $8.17K and leaving 12,873 shares worth $15.4M. The position accounts for 1.8% of the portfolio, ranked #22.

Alley Investment Management Company first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alley Investment Management Company held 12,873 shares of Eli Lilly worth $15.4M as of Q2 2026.
  • Alley Investment Management Company sold 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 1.8% of Alley Investment Management Company's portfolio in Q2 2026, its #22 holding.
  • Alley Investment Management Company first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alley Investment Management Company's 13F filing for Q2 2026, filed 23 Jul 2026.